Scientists are researching how to take stem cells from the patient’s blood to repair damage to the heart. A new therapy could reduce the need for operations, the U.K.’s Express newspaper reports, with researchers hoping the therapy could save lives while being cost effective.
Patients who progressed to having longer episodes of subclinical atrial fibrillation (SCAF) were more than four times as likely to be hospitalized for heart failure in a one-year span, according to a study published June 4 in the Journal of the American College of Cardiology.
Measurements of malnutrition offer incremental prognostic value for patients with heart failure, but more work is needed to tease out which components of the condition are most crucial to calculate and treat, researchers reported in JACC: Heart Failure.
The average hospital stay for pediatric patients requiring a ventricular assist device (VAD) spans nearly three months and costs $750,000, according to research in the Journal of the American Heart Association.
Researchers have found the HeartMate 3 (HM3) left-ventricular assist device (LVAD) improves long-term outcomes and may also decrease the cost of care overtime for heart failure patients compared to the HeartMate II (HMII).
The electrical connection between the ventricular assist device (VAD)'s power source and its controller may be interrupted due to oxidation on the connecting surfaces, according to the agency’s recall notice.
Baylor St. Luke’s Medical Center in Houston has temporarily suspended its heart transplant program, two weeks after a joint investigation by the Houston Chronicle and ProPublica detailed its poor performance.
Type 2 diabetics who take sodium-glucose co-transporter-2 (SGLT-2) inhibitors experience similar relative reductions in heart failure and mortality regardless of whether they have cardiovascular disease (CVD), according to a subanalysis of the CVD-REAL study published in the Journal of the American College of Cardiology.
Adding biomarkers to the validated Pooled Cohort Equation (PCE) can improve predictions of cardiovascular events including heart attack, stroke and heart failure among older patients, researchers reported in the Journal of the American College of Cardiology.
Severe and active atopic eczema in adulthood is associated with an increased risk for developing cardiovascular disease (CVD), including stroke, heart failure, myocardial infarction (MI) and atrial fibrillation (AFib), according to a new study published May 23 in The BMJ.
Several models have been developed to predict mortality among heart failure patients, but clinicians remain reluctant to use them in everyday practice. In fact, fewer than 1 percent of patients received a prognostic estimate from their physicians in a European registry analysis published in JACC: Heart Failure.
Triggering a shift in fluids from the chest to the abdomen by blocking the splanchnic nerves has the potential to relieve acute heart failure symptoms, according to research presented May 26 at Heart Failure 2018 and published simultaneously in Circulation.
Middle-aged men who eat higher amounts of protein are associated with a slightly elevated risk for heart failure (HF) than those who eat less protein, according to a new study published in Circulation: Heart Failure on May 29. There is a limited amount of information regarding how diets high in protein impact men’s HF risk.
Heart failure patients who were given instructions on how to use a Nintendo Wii device—which incorporates physical activity into video gaming—improved their exercise capacity and quality of life more than counterparts who were simply advised to exercise 30 minutes per day.
Patients with heart failure who describe themselves as being socially isolated have an increased risk of death and also have an increased use of healthcare resources, according to new research published in the Journal of the American Heart Association on May 23.
The FDA has issued a Class I recall of the HeartMate 3 Left Ventricular Assist System (Abbott) because a malfunction in the device’s outflow graft assembly could lead to graft occlusion, possibly reducing or stopping blood flow.
A study published May 8 in the Journal of the American Heart Association suggests black and white patients with heart failure with reduced ejection fraction (HFrEF) derive similar benefit from beta-blockers, despite conflicting previous reports.